Elixir Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-12-2024
- Paid Up Capital ₹ 0.30 M
as on 18-12-2024
- Company Age 18 Year, 15 Days
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 12.04 Cr
as on 18-12-2024
- Revenue %
(FY 2019)
- Profit 25.00%
(FY 2019)
- Ebitda 25.00%
(FY 2019)
- Net Worth -0.01%
(FY 2019)
- Total Assets -0.02%
(FY 2019)
About Elixir Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹12.04 Cr.
Kamlesh Shah, Girish Joshi, and Prashant Bhamare serve as directors at the Company.
- CIN/LLPIN
U85110MH2007PTC166863
- Company No.
166863
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2007
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Elixir Hospital?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Bhamare  | Managing Director | 12-Mar-2015 | Current |
| Girish Joshi | Managing Director | 12-Mar-2015 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Shah | Director | 09-Jan-2007 | Current |
Financial Performance of Elixir Hospital.
Elixir Hospital Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 25% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elixir Hospital?
In 2019, Elixir Hospital had a promoter holding of 0.67% and a public holding of 99.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vedantaa Institutes Of Academic Excellence AssociationActive 5 years 4 months
Kamlesh Shah is a mutual person
- Vedantaa Institutes Of Academic Excellence Private LimitedActive 13 years 5 months
Kamlesh Shah is a mutual person
Charges (Loans)
₹120.40 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 12.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2007 | Bank Of Baroda | ₹6.02 Cr | Open |
| 24 Dec 2007 | Bank Of Baroda | ₹6.02 Cr | Open |
How Many Employees Work at Elixir Hospital?
Unlock and access historical data on people associated with Elixir Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elixir Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
